$BioLargo, Inc.(BLGO)$Discusses Development and Scale-Up of Its PFAS Treatment Technology and 2022 Commercial Plans With The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - December 16, 2021) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, wastewater treatment, and industrial odor and VOC control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview.

Jolly began by asking about BioLargo's consumer products strategic partnership with Ikigai Holdings. "Ikigai is a company that is focused on launching consumer products," explained Calvert. "The partners at Ikigai have launched at least five blockbuster products in their careers," he said, adding that they are "experts in the art of launching products that can build into a national brand." He added, "We have bargained to be the supply chain partner. So, we're wholesaling our product, earning a royalty on the technology, and then participating in a minority way on the exit."

Jolly then asked about the progress of BioLargo's Garratt-Callahan partnership. "Garratt-Callahan is the largest privately held water [treatment] company in America," said Calvert. "We joined them as a technical expert to bring forth engineering and science to develop a product according to a design that they had created," he explained. "That product is being tested now," said Calvert. "We're hoping to launch very early in 2022."

The conversation then turned to the commercialization of BioLargo's technology that eliminates per- and polyfluoroalkyl substances (PFAS), a class of water contaminants of rising concern because of their ubiquity in water around the world and their long-term health effects. "The Biden administration has listed [PFAS] as one of the top environmental issues of the decade," said Calvert. "We have a device and expertise that provides selective extraction [of PFAS] … [It generates] 1/1000 the waste that's created for disposal of the competition."

The company hopes to get its PFAS treatment technology, called the Aqueous Electrostatic Concentrator, commercialized in 2022 in part by partnering with established players in the water treatment industry. "These projects could range [from] half a million all the way up to [the] fifteen million dollar range," Calvert explained. "I think this is a huge opportunity for BioLargo to create value for our shareholders, so we are very excited."

To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7998255-biolargo-inc-discusses-development-and-scale-up-of-its-pfas-treatment-technology-and-2022-comme